Description:
Lacidipine is a group of type calcium channel blocker drug. Lacidipine works by relaxing the heart muscle and blood vessels.
Indications:
To treat high blood pressure (hypertension).
Dosage:
The initial dose: 2 mg by mouth (orally), 1 times daily
May be increased to 4 mg, if necessary to 6 mg by mouth (orally), 1 time a day after at least 3-4 weeks away.
Side Effects:
CV effects (decreased cardiac function, hypotension, heart failure is getting worse, edema, skin redness, bradycardia), GI effects (constipation); CNS effects (headache, dizziness).
HR regulate calcium antagonists (Diltiazem, Gallopamil & verapamil); AV dissociation, AV block, bradycardia, and sinus stem dysfunction.
Short-acting dihydropyridine agents should be avoided because it has the potential to increase the risk of adverse cardiac events.
Special Instructions:
Contraindicated in patients who clearly have decompensated HR, although vasoselective dihydropyridine (eg Amlodipine and Felodipine) can be accepted by patients with reduced LV solution.
HR which regulates calcium antagonists contraindicated in patients with bradycardia, sinus stem dysfunction, and AV nodal block.
Lacidipine is a group of type calcium channel blocker drug. Lacidipine works by relaxing the heart muscle and blood vessels.
Indications:
To treat high blood pressure (hypertension).
Dosage:
The initial dose: 2 mg by mouth (orally), 1 times daily
May be increased to 4 mg, if necessary to 6 mg by mouth (orally), 1 time a day after at least 3-4 weeks away.
Side Effects:
CV effects (decreased cardiac function, hypotension, heart failure is getting worse, edema, skin redness, bradycardia), GI effects (constipation); CNS effects (headache, dizziness).
HR regulate calcium antagonists (Diltiazem, Gallopamil & verapamil); AV dissociation, AV block, bradycardia, and sinus stem dysfunction.
Short-acting dihydropyridine agents should be avoided because it has the potential to increase the risk of adverse cardiac events.
Special Instructions:
Contraindicated in patients who clearly have decompensated HR, although vasoselective dihydropyridine (eg Amlodipine and Felodipine) can be accepted by patients with reduced LV solution.
HR which regulates calcium antagonists contraindicated in patients with bradycardia, sinus stem dysfunction, and AV nodal block.
This is the right site for anyone who hopes to find out about this topic.
ReplyDeleteYou know a whole lot its almost tough to argue with you (not that I actually
will need to_HaHa). You definitely put a brand new spin on a topic
which has been discussed for years. Great stuff, just
great!